Speeches, Articles and Testimony

Refine your results

Displaying 381 - 400 of 3933

Show:

Remarks of Chair Khan As Prepared for Delivery Creative Economy and Generative AI Roundtable

Date

4 de Oct de 2023

Lina M. Khan, Former Chair and Commissioner

Remarks of Chair Khan As Prepared for Delivery Creative Economy and Generative AI Roundtable (188.56 KB)

Remarks of Chair Lina M. Khan as Prepared for Delivery at the Fordham 50th Annual Conference on International Antitrust Law & Policy

Date

22 de Sep de 2023

Lina M. Khan, Former Chair and Commissioner

Remarks of Chair Lina M. Khan as Prepared for Delivery - Fordham 50th Annual Conference on International Antitrust Law & Policy (235.91 KB)

Remarks of BCP Director Samuel Levine at 2023 Consumer Data Industry Association Law & Industry Conference

Date

21 de Sep de 2023

Samuel Levine, Former Director, Bureau of Consumer Protection

Remarks of BCP Director Samuel Levine at 2023 Consumer Data Industry Association Law & Industry Conference (262.74 KB)

Remarks of BCP Director Samuel Levine at The National Advertising Division Annual Conference 2023

Date

19 de Sep de 2023

Samuel Levine, Former Director, Bureau of Consumer Protection

Remarks of BCP Director Samuel Levine at The National Advertising Division Annual Conference 2023 (337.35 KB)

Federal Trade Commission Statement Concerning Brand Drug Manufacturers' Improper Listing of Patents in the Orange Book

Concerning Brand Drug Manufacturers' Improper Listing of Patents in the Orange Book

Date

14 de Sep de 2023

Matter Number

P233900

Federal Trade Commission (FTC)

Text of the Policy Statement (633.47 KB)

Related Releases

FTC Issues Policy Statement on Brand Pharmaceutical Manufacturers’ Improper Listing of Patents in the Food and Drug Administration’s ‘Orange Book’

Statement of Chair Lina M. Khan at the September Open Commission Meeting on Brand Drug Manufacturers’ Improper Listing of Patents in the Orange Book

Date

14 de Sep de 2023

Lina M. Khan, Former Chair and Commissioner

Statement of Chair Lina M. Khan at the September Open Commission Meeting on Brand Drug Manufacturers’ Improper Listing of Patents in the Orange Book (186.42 KB)

Related Releases

FTC Issues Policy Statement on Brand Pharmaceutical Manufacturers’ Improper Listing of Patents in the Food and Drug Administration’s ‘Orange Book’

Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc

Date

1 de Sep de 2023

Lina M. Khan, Former Chair and Commissioner;

Alvaro Bedoya, Former Commissioner;

Rebecca Kelly Slaughter, Former Commissioner

Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc (231.33 KB)

Related Releases

Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition

Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc

Date

1 de Sep de 2023

Lina M. Khan, Former Chair and Commissioner;

Alvaro Bedoya, Former Commissioner;

Rebecca Kelly Slaughter, Former Commissioner

Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc (231.33 KB)

Related Releases

Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition

Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc

Date

1 de Sep de 2023

Lina M. Khan, Former Chair and Commissioner;

Alvaro Bedoya, Former Commissioner;

Rebecca Kelly Slaughter, Former Commissioner

Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc (231.33 KB)

Related Releases

Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition

Statement of Chair Lina M. Khan, Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya, in the Matter of EQT Corporation

In the Matter of EQT Corporation

Date

16 de Ago de 2023

Matter Number

2210212

Lina M. Khan, Former Chair and Commissioner;

Rebecca Kelly Slaughter, Former Commissioner;

Alvaro Bedoya, Former Commissioner

Statement of Chair Khan, Joined by Commissioners Slaughter and Bedoya, in In the Matter of EQT Corporation (253.12 KB)

Related Releases

FTC Acts to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal

Statement of Chair Lina M. Khan, Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya, in the Matter of EQT Corporation

In the Matter of EQT Corporation

Date

16 de Ago de 2023

Matter Number

2210212

Lina M. Khan, Former Chair and Commissioner;

Rebecca Kelly Slaughter, Former Commissioner;

Alvaro Bedoya, Former Commissioner

Statement of Chair Khan, Joined by Commissioners Slaughter and Bedoya, in In the Matter of EQT Corporation (253.12 KB)

Related Releases

FTC Acts to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal

Statement of Chair Lina M. Khan, Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya, in the Matter of EQT Corporation

In the Matter of EQT Corporation

Date

16 de Ago de 2023

Matter Number

2210212

Lina M. Khan, Former Chair and Commissioner;

Rebecca Kelly Slaughter, Former Commissioner;

Alvaro Bedoya, Former Commissioner

Statement of Chair Khan, Joined by Commissioners Slaughter and Bedoya, in In the Matter of EQT Corporation (253.12 KB)

Related Releases

FTC Acts to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal

Letter from Chair Lina M. Khan to Chairman Jim Jordan, House Committee on the Judiciary, Concerning the FTC's Responsiveness to Committee Requests

Letter to Representative Jim Jordan, Chair, House Committee on the Judiciary

Date

11 de Ago de 2023

Lina M. Khan, Former Chair and Commissioner

Text of the Letter (112.07 KB)

Remarks from Chief Technology Officer, Stephanie T. Nguyen As Prepared for Delivery At the Department of Trade and Industry – Manila, Philippines US-Philippines Bilateral Workshop on Consumer Protection in the Tech Sector

Date

7 de Ago de 2023

Stephanie Nguyen, Former Chief Technologist

Remarks from Chief Technology Officer, Stephanie T. Nguyen As Prepared for Delivery At the Department of Trade and Industry – Manila, Philippines US-Philippines Bilateral Workshop on Consumer Protection in the Tech Sector (324.06 KB)

Letter from FTC Chair Lina M. Khan to Chairman Jim Jordan on Committee Harassment of FTC Career Staff

Date

26 de Jul de 2023

Lina M. Khan, Former Chair and Commissioner

Letter from FTC Chair Lina M. Khan to Chairman Jim Jordan on Committee Harassment of FTC Career Staff (116.19 KB)

Remarks of Chair Lina M. Khan at Economic Club of New York

Date

25 de Jul de 2023

Lina M. Khan, Former Chair and Commissioner

Remarks of Chair Lina M. Khan at Economic Club of New York (246.18 KB)

Statement of Chair Lina M. Khan Regarding the Policy Statement Concerning Reliance on Prior PBM-Related Advocacy Statements and Reports

Date

20 de Jul de 2023

Lina M. Khan, Former Chair and Commissioner

Statement of Chair Lina M. Khan Regarding the Policy Statement Concerning Reliance on Prior PBM-Related Advocacy Statements and Reports (145.49 KB)

Related Releases

FTC Votes to Issue Statement Withdrawing Prior Pharmacy Benefit Manager Advocacy

Statement of Commissioner Rebecca Kelly Slaughter Regarding the Health Breach Notification Rule and the Biometric Policy Statement as Prepared for Delivery

Date

20 de Jul de 2023

Rebecca Kelly Slaughter, Former Commissioner

Statement of Commissioner Rebecca Kelly Slaughter Regarding the Health Breach Notification Rule and the Biometric Policy Statement as Prepared for Delivery (151.49 KB)

Related Releases

FTC Votes to Issue Statement Withdrawing Prior Pharmacy Benefit Manager Advocacy

Statement of Commissioner Alvaro M. Bedoya Joined by Chair Lina M. Khan and Commissioner Rebecca Kelly Slaughter Regarding the Proposed Merger Guidelines Issued by the Federal Trade Commission & U.S. Department of Justice

Date

19 de Jul de 2023

Matter Number

P234000

Alvaro Bedoya, Former Commissioner

Statement of Commissioner Alvaro M. Bedoya Joined by Chair Lina M. Khan and Commissioner Rebecca Kelly Slaughter Regarding FTC-DOJ Proposed Merger Guidelines (299.73 KB)

Related Releases

FTC and DOJ Seek Comment on Draft Merger Guidelines

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines

Date

19 de Jul de 2023

Matter Number

P234000

Lina M. Khan, Former Chair and Commissioner

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines (196.08 KB)

Related Releases

FTC and DOJ Seek Comment on Draft Merger Guidelines

Displaying 381 - 400 of 3933

Join us at the FTC!

View our open positions

Speeches, Articles and Testimony by

Refine your results

Refine your results